Health · Full coverage
Health Ministry Orders Recall of Potentially Dangerous Drug IMAAVY
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Unrated 2
By Алекс Липницкий
First reported by Mignews · 20 hours ago
What happened
Israel's Ministry of Health has ordered the recall of the drug IMAAVY due to potential glass particle contamination in specific batches. The drug, distributed by Johnson & Johnson, is used to treat myasthenia gravis, and the recall is not expected to cause a shortage.
- 01Health Ministry orders recall of IMAAVY drug due to glass particle risk.
- 02Johnson & Johnson is the distributor of the affected drug in Israel.
- 03IMAAVY treats generalized myasthenia gravis in adults and adolescents.
- 04Medical facilities must stop using, isolate, and return recalled batches.
- 05Recall is not expected to lead to a drug shortage in Israel.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Health Ministry Recalls Ground Black Pepper Due to Toxin Contamination6 days agoIsraeli Health Ministry Recalls Popular Njoy and Joicy Soft Drinks Over Health RisksAug 20, 2026Health Ministry Halts Use of Similac Batch in Israeli Hospitals2 days agoHealth Ministry Recalls Jams Due to Unusual Odor and TextureSep 10, 2026Health Ministry Explains Why No Recall Was Ordered After Frionic Tainted Pouches FoundJun 19, 2026Israeli Health Ministry Orders Boiling Water in Avivim Settlement After ContaminationJun 29, 2026
